Radiology· 2020Q1
Coronavirus Disease 2019 (COVID-19): A Perspective from China
- 2,149citations
- Q1SCImago
- 2020year
Short summary
Chest CT findings are crucial for early diagnosis and disease assessment of COVID-19 pneumonia, serving as major evidence for clinical diagnosis in Hubei, China.
AI-generated from the title and abstract; the full text is not read.
Key points
- COVID-19, caused by SARS-CoV-2, originated in Wuhan, China, in December 2019.
- Most COVID-19 patients develop pneumonia with characteristic CT imaging patterns.
- Chest CT findings are essential for early diagnosis and assessing disease course.
- CT findings are considered major evidence for clinical diagnosis in Hubei, China.
AI-generated from the title and abstract; the full text is not read.
Abstract
In December 2019, an outbreak of severe acute respiratory syndrome coronavirus 2 infection occurred in Wuhan, Hubei Province, China, and spread across China and beyond. On February 12, 2020, the World Health Organization officially named the disease caused by the novel coronavirus as coronavirus disease 2019 (COVID-19). Because most patients infected with COVID-19 had pneumonia and characteristic CT imaging patterns, radiologic examinations have become vital in early diagnosis and the assessment of disease course. To date, CT findings have been recommended as major evidence for clinical diagnosis of COVID-19 in Hubei, China. This review focuses on the etiology, epidemiology, and clinical symptoms of COVID-19 while highlighting the role of chest CT in prevention and disease control.
The authors' abstract, as published at the source. Radiology, 2020 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Radiology, Nuclear Medicine and Imaging
Radiology, Nuclear Medicine and ImagingMedicine